CA Stock MarketDetailed Quotes

WPD Pharmaceuticals Inc (WBIO)

Watchlist
  • 0.070
  • 0.0000.00%
15min DelayMarket Closed Feb 20 14:09 ET
324.76KMarket Cap-3.89P/E (TTM)

WPD Pharmaceuticals Inc (WBIO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.80%-31.58K
90.40%-7.79K
-261.09%-75.02K
94.02%-205.1K
92.24%-57.6K
98.74%-45.64K
-103.69%-81.09K
98.36%-20.78K
-3.43M
-742.29K
Net income from continuing operations
155.36%47.52K
75.84%-19K
-315.11%-157.62K
-102.08%-80.08K
-98.02%122.39K
97.68%-85.85K
-104.02%-78.65K
93.36%-37.97K
--3.86M
--6.17M
Operating gains losses
---69.55K
----
----
----
----
----
----
----
---4.52M
----
Depreciation and amortization
-22.86%2.71K
--2.71K
--2.71K
-74.16%6.31K
-55.02%2.81K
-58.87%3.51K
--0
--0
--24.44K
--6.24K
Asset impairment expenditure
----
----
----
6.56%32.08K
----
----
----
----
--30.1K
--11.83K
Unrealized gains and losses of investment securities
----
----
----
---224.47K
----
----
----
----
--0
----
Remuneration paid in stock
----
----
----
--0
----
----
----
----
--44.18K
--5.78K
Other non cashItems
-283.17%-32.65K
---68.57K
--15.37K
-78.24%36.45K
-54.79%13.63K
-99.37%17.83K
----
----
--167.52K
--30.15K
Change In working capital
8.03%20.39K
1,067.60%71.86K
275.24%64.52K
100.81%24.61K
99.84%-4.03K
8.09%18.88K
-104.90%-7.43K
102.27%17.19K
---3.03M
---2.44M
-Change in receivables
42.78%-2.04K
-98.57%-4.73K
-222.72%-4.82K
79.15%-12.6K
-102.22%-5.15K
95.91%-3.57K
97.38%-2.38K
98.69%-1.49K
---60.41K
--232.12K
-Change in prepaid assets
----
----
----
-110.00%-3.5K
1,279.25%7.5K
----
----
----
--35K
---636
-Change in payables and accrued expense
-32.92%22.43K
1,618.90%76.6K
271.05%69.33K
102.82%40.71K
99.42%-6.38K
-80.97%33.44K
-101.52%-5.04K
102.21%18.69K
---1.44M
---1.11M
-Change in other working capital
----
----
----
----
----
----
----
----
---1.56M
---1.57M
Cash from discontinued investing activities
Operating cash flow
30.80%-31.58K
90.40%-7.79K
-261.09%-75.02K
94.02%-205.1K
92.24%-57.6K
94.61%-45.64K
85.86%-81.09K
98.36%-20.78K
---3.43M
---742.29K
Investing cash flow
Cash flow from continuing investing activities
0
0
-239.05K
-216.65K
Net intangibles purchas and sale
----
----
----
--0
----
----
----
----
---36.35K
---13.95K
Net business purchase and sale
----
----
----
--0
----
----
----
----
---202.71K
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
--0
----
----
----
---239.05K
---216.65K
Financing cash flow
Cash flow from continuing financing activities
192.89%30.5K
-78.20%267.17K
0
-657.44%-32.84K
1.23M
500.98K
Net issuance payments of debt
192.89%30.5K
----
----
-63.00%267.17K
--0
-657.44%-32.84K
----
----
--722.09K
---2.4K
Net other financing activities
----
----
----
----
----
----
----
----
--503.37K
----
Cash from discontinued financing activities
Financing cash flow
192.89%30.5K
----
----
-78.20%267.17K
--0
-657.44%-32.84K
----
----
--1.23M
--500.98K
Net cash flow
Beginning cash position
-98.62%3.05K
-52.91%10.84K
260.85%85.86K
-98.61%23.79K
-27.16%143.46K
-70.84%221.93K
-97.44%23.02K
-98.61%23.79K
--1.71M
--196.96K
Current changes in cash
108.01%6.29K
-103.91%-7.79K
-9,567.65%-75.02K
102.54%62.07K
87.42%-57.6K
90.78%-78.47K
156.70%198.91K
99.90%-776
---2.44M
---457.96K
Effect of exchange rate changes
----
----
----
--0
----
----
----
----
--757.92K
--284.8K
End cash Position
-93.49%9.34K
-98.62%3.05K
-52.91%10.84K
260.85%85.86K
260.85%85.86K
-27.16%143.46K
-70.84%221.93K
-97.44%23.02K
--23.79K
--23.79K
Free cash from
30.80%-31.58K
90.40%-7.79K
-261.09%-75.02K
94.08%-205.1K
92.38%-57.6K
94.61%-45.64K
86.39%-81.09K
98.36%-20.78K
---3.47M
---756.23K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.80%-31.58K90.40%-7.79K-261.09%-75.02K94.02%-205.1K92.24%-57.6K98.74%-45.64K-103.69%-81.09K98.36%-20.78K-3.43M-742.29K
Net income from continuing operations 155.36%47.52K75.84%-19K-315.11%-157.62K-102.08%-80.08K-98.02%122.39K97.68%-85.85K-104.02%-78.65K93.36%-37.97K--3.86M--6.17M
Operating gains losses ---69.55K-------------------------------4.52M----
Depreciation and amortization -22.86%2.71K--2.71K--2.71K-74.16%6.31K-55.02%2.81K-58.87%3.51K--0--0--24.44K--6.24K
Asset impairment expenditure ------------6.56%32.08K------------------30.1K--11.83K
Unrealized gains and losses of investment securities ---------------224.47K------------------0----
Remuneration paid in stock --------------0------------------44.18K--5.78K
Other non cashItems -283.17%-32.65K---68.57K--15.37K-78.24%36.45K-54.79%13.63K-99.37%17.83K----------167.52K--30.15K
Change In working capital 8.03%20.39K1,067.60%71.86K275.24%64.52K100.81%24.61K99.84%-4.03K8.09%18.88K-104.90%-7.43K102.27%17.19K---3.03M---2.44M
-Change in receivables 42.78%-2.04K-98.57%-4.73K-222.72%-4.82K79.15%-12.6K-102.22%-5.15K95.91%-3.57K97.38%-2.38K98.69%-1.49K---60.41K--232.12K
-Change in prepaid assets -------------110.00%-3.5K1,279.25%7.5K--------------35K---636
-Change in payables and accrued expense -32.92%22.43K1,618.90%76.6K271.05%69.33K102.82%40.71K99.42%-6.38K-80.97%33.44K-101.52%-5.04K102.21%18.69K---1.44M---1.11M
-Change in other working capital -----------------------------------1.56M---1.57M
Cash from discontinued investing activities
Operating cash flow 30.80%-31.58K90.40%-7.79K-261.09%-75.02K94.02%-205.1K92.24%-57.6K94.61%-45.64K85.86%-81.09K98.36%-20.78K---3.43M---742.29K
Investing cash flow
Cash flow from continuing investing activities 00-239.05K-216.65K
Net intangibles purchas and sale --------------0-------------------36.35K---13.95K
Net business purchase and sale --------------0-------------------202.71K----
Cash from discontinued investing activities
Investing cash flow --------------0--0---------------239.05K---216.65K
Financing cash flow
Cash flow from continuing financing activities 192.89%30.5K-78.20%267.17K0-657.44%-32.84K1.23M500.98K
Net issuance payments of debt 192.89%30.5K---------63.00%267.17K--0-657.44%-32.84K----------722.09K---2.4K
Net other financing activities ----------------------------------503.37K----
Cash from discontinued financing activities
Financing cash flow 192.89%30.5K---------78.20%267.17K--0-657.44%-32.84K----------1.23M--500.98K
Net cash flow
Beginning cash position -98.62%3.05K-52.91%10.84K260.85%85.86K-98.61%23.79K-27.16%143.46K-70.84%221.93K-97.44%23.02K-98.61%23.79K--1.71M--196.96K
Current changes in cash 108.01%6.29K-103.91%-7.79K-9,567.65%-75.02K102.54%62.07K87.42%-57.6K90.78%-78.47K156.70%198.91K99.90%-776---2.44M---457.96K
Effect of exchange rate changes --------------0------------------757.92K--284.8K
End cash Position -93.49%9.34K-98.62%3.05K-52.91%10.84K260.85%85.86K260.85%85.86K-27.16%143.46K-70.84%221.93K-97.44%23.02K--23.79K--23.79K
Free cash from 30.80%-31.58K90.40%-7.79K-261.09%-75.02K94.08%-205.1K92.38%-57.6K94.61%-45.64K86.39%-81.09K98.36%-20.78K---3.47M---756.23K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
U.S.-Iran negotiations stalled over the weekend, with both sides deadlocked over the disposition of nuclear materials and terms related to t Show More